Verve Therapeutics【VERV】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

4.57

買値

4.52

売値

4.64

出来高

2,594,072

4.43 日の範囲 4.84

2.8647 52 週間の範囲 9.305

時価総額

405.797M

前日終値

4.51

始値

4.56

時刻

4.64

最終取引時間

財務取引量

US$ 11,971,691

VWAP

4.615

平均取引量 (3 か月)

2,534,459

発行済株式数

88,795,768

配当利回り

PER

-2.05

1 株当たり利益 (EPS)

-2.24

歳入

32.33M

純利益

-198.71M

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.vervetx.com

本社

Wilmington, Delaware, USA

設立

Verve Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker VERV. The last closing price for Verve Therapeutics was US$4.51. Over the last year, Verve Therapeutics shares have traded in a share price range of US$ 2.8647 to US$ 9.305.

Verve Therapeutics currently has 88,795,768 shares in issue. The market capitalisation of Verve Therapeutics is US$400.47 million. Verve Therapeutics has a price to earnings ratio (PE ratio) of -2.05.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in...

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

BOSTON, April 11, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.26	38.0664652568	3.31	5.81	2.94	13554662	4.40662427	CS
4	-1.25	-21.4776632302	5.82	5.99	2.8647	4769272	4.32376616	CS
12	-3.42	-42.8035043805	7.99	9.305	2.8647	2534459	5.31733464	CS
26	-1	-17.9533213645	5.57	9.305	2.8647	2013725	5.58268108	CS
52	-2.66	-36.7911479945	7.23	9.305	2.8647	1680677	5.61967668	CS
156	-15.45	-77.1728271728	20.02	43	2.8647	1224434	12.55996193	CS
260	-25.43	-84.7666666667	30	78	2.8647	1075055	15.40799961	CS

VERV - Frequently Asked Questions (FAQ)

What is the current Verve Therapeutics share price?

The current share price of Verve Therapeutics is US$ 4.57

How many Verve Therapeutics shares are in issue?

Verve Therapeutics has 88,795,768 shares in issue

What is the market cap of Verve Therapeutics?

The market capitalisation of Verve Therapeutics is USD 400.47M

What is the 1 year trading range for Verve Therapeutics share price?

Verve Therapeutics has traded in the range of US$ 2.8647 to US$ 9.305 during the past year

What is the PE ratio of Verve Therapeutics?

The price to earnings ratio of Verve Therapeutics is -2.05

What is the cash to sales ratio of Verve Therapeutics?

The cash to sales ratio of Verve Therapeutics is 12.58

What is the reporting currency for Verve Therapeutics?

Verve Therapeutics reports financial results in USD

What is the latest annual turnover for Verve Therapeutics?

The latest annual turnover of Verve Therapeutics is USD 32.33M

What is the latest annual profit for Verve Therapeutics?

The latest annual profit of Verve Therapeutics is USD -198.71M

What is the registered address of Verve Therapeutics?

The registered address for Verve Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Verve Therapeutics website address?

The website address for Verve Therapeutics is www.vervetx.com

Which industry sector does Verve Therapeutics operate in?

Verve Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MSGMMotorsport Games Inc	US$ 2.69 (140.18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.11 (113.37%)	51.73M
ADGMAdagio Medical Holdings Inc	US$ 1.68 (81.98%)	115.48M
PNBKPatriot National Bancorp Inc	US$ 3.28 (73.54%)	1.57M
RTCBaijiayun Group Ltd	US$ 0.3601 (67.49%)	187.02M
LXEHLixiang Education Holding Company Ltd	US$ 8.25 (-64.11%)	1.55M
CLIKClick Holdings Ltd	US$ 0.355 (-48.18%)	13.52M
IOTRiOThree Ltd	US$ 1.1409 (-38.33%)	3.93M
FMTOFemto Technologies Inc	US$ 0.0191 (-35.47%)	198.4M
SISIShineco Inc	US$ 0.5809 (-35.07%)	824.91k
DMNDamon Inc	US$ 0.0034 (9.68%)	409.39M
STSSSharps Technology Inc	US$ 0.03195 (20.57%)	391.8M
SUNESUNation Energy Inc	US$ 0.0176 (-10.20%)	349.4M
NVDANVIDIA Corporation	US$ 101.49 (-2.87%)	292.48M
HTZHertz Global Holdings Inc	US$ 8.205 (43.70%)	266.91M